Impact of prospective screening for multiple endocrine neoplasia type 2

Henry Ford Hosp Med J. 1987;35(2-3):94-8.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Gland Diseases / prevention & control
  • Adrenal Gland Neoplasms / prevention & control*
  • Adrenal Medulla
  • Adrenalectomy
  • Adult
  • Calcitonin / blood
  • Carcinoma / prevention & control*
  • Catecholamines / urine
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperplasia
  • Middle Aged
  • Multiple Endocrine Neoplasia / genetics
  • Multiple Endocrine Neoplasia / prevention & control*
  • Parathyroid Glands / pathology
  • Parathyroid Hormone / blood
  • Pedigree
  • Pheochromocytoma / prevention & control*
  • Prospective Studies
  • Radioimmunoassay
  • Thyroid Gland / pathology
  • Thyroid Neoplasms / prevention & control*
  • Thyroidectomy
  • Time Factors

Substances

  • Catecholamines
  • Parathyroid Hormone
  • Calcitonin